Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture
- PMID: 6181386
Specific binding of an immunoreactive and biologically active 125I-labeled substance P derivative to mouse mesencephalic cells in primary culture
Abstract
Binding characteristics of 125I-labeled Bolton-Hunter substance P ([125I]BHSP), a radioactive analogue of substance P, were studied with mesencephalic primary cultures prepared from embryonic mouse brain. Nonspecific binding represented no more than 20% of the total binding observed on the cells. In contrast, significant specific binding--saturable, reversible, and temperature-dependent--was demonstrated. Scatchard analysis of concentration-dependent binding saturation indicates a single population of noninteracting sites with a high affinity (Kd = 169 pM). Substance P and different substance P analogues were tested for their competitive potencies with regard to [125I]BHSP binding. BHSP itself, substance P, (Tyr8)-substance P, and (nor-Leu11)-substance P strongly inhibited the binding. Good inhibition was also obtained with physalaemin and eledoisin, two peptides structurally related to substance P. When substance P C-terminal fragments were tested for their ability to compete with [125I]BHSP binding, a good relationship was found between competitive activity and peptide length. Regional distribution of [125I]BHSP binding sites was found using primary cultures obtained from different regions of embryonic mouse brain. Mesencephalic, hypothalamic, and striatal cultures had the highest [125I]BHSP binding capacities, whereas cortical, hippocampal, and cerebellar cells shared only little binding activity. Finally, when mesencephalic cells were grown under conditions impairing glial development, [125I]BHSP binding was not affected, demonstrating that binding sites are located on neuronal cells.
Similar articles
-
A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative.Mol Pharmacol. 1984 Sep;26(2):248-54. Mol Pharmacol. 1984. PMID: 6207421
-
Specific binding of a 125I-labeled substance P analog to rat submaxillary gland.J Pharmacol Exp Ther. 1984 Jul;230(1):116-23. J Pharmacol Exp Ther. 1984. PMID: 6205134
-
Marked regional heterogeneity of 125I-Bolton Hunter substance P binding and substance P-induced activation of phospholipase C in astrocyte cultures from the embryonic or newborn rat.J Neurochem. 1990 Feb;54(2):669-75. doi: 10.1111/j.1471-4159.1990.tb01923.x. J Neurochem. 1990. PMID: 1688922
-
An isolated growth cone-enriched fraction from developing rat brain has substance P binding sites.Brain Res. 1988 May 1;468(1):1-9. doi: 10.1016/0165-3806(88)90002-8. Brain Res. 1988. PMID: 2454147
-
Localization and characterization of substance P binding sites in rat and rabbit eyes.Invest Ophthalmol Vis Sci. 1991 May;32(6):1894-902. Invest Ophthalmol Vis Sci. 1991. PMID: 1709627
Cited by
-
The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy.Pharmaceutics. 2019 Sep 1;11(9):443. doi: 10.3390/pharmaceutics11090443. Pharmaceutics. 2019. PMID: 31480582 Free PMC article. Review.
-
Substance P receptors in primary cultures of cortical astrocytes from the mouse.Proc Natl Acad Sci U S A. 1986 Dec;83(23):9216-20. doi: 10.1073/pnas.83.23.9216. Proc Natl Acad Sci U S A. 1986. PMID: 2431412 Free PMC article.
-
The postsynaptic targets of substance P-immunoreactive terminals in the rat neostriatum with particular reference to identified spiny striatonigral neurons.Exp Brain Res. 1988;70(2):361-77. doi: 10.1007/BF00248361. Exp Brain Res. 1988. PMID: 2454839
-
International Substance P Symposium. Dublin, April 27-29, 1983. Abstracts.Ir J Med Sci. 1983;152 Suppl 1:11-70. Ir J Med Sci. 1983. PMID: 6190773 No abstract available.
-
Interactions between tachykinins and diverse, human nicotinic acetylcholine receptor subtypes.Neurochem Res. 1996 Oct;21(10):1245-57. doi: 10.1007/BF02532402. Neurochem Res. 1996. PMID: 8923487